JPS60209530A - 殺腫瘍性物質 - Google Patents

殺腫瘍性物質

Info

Publication number
JPS60209530A
JPS60209530A JP59066330A JP6633084A JPS60209530A JP S60209530 A JPS60209530 A JP S60209530A JP 59066330 A JP59066330 A JP 59066330A JP 6633084 A JP6633084 A JP 6633084A JP S60209530 A JPS60209530 A JP S60209530A
Authority
JP
Japan
Prior art keywords
molecular weight
cells
tkf
present
lectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59066330A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0144199B2 (enExample
Inventor
Shunji Natori
俊二 名取
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Teijin Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Teijin Ltd
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd, Teijin Ltd, Yoshitomi Pharmaceutical Industries Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Priority to JP59066330A priority Critical patent/JPS60209530A/ja
Publication of JPS60209530A publication Critical patent/JPS60209530A/ja
Publication of JPH0144199B2 publication Critical patent/JPH0144199B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP59066330A 1984-04-02 1984-04-02 殺腫瘍性物質 Granted JPS60209530A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59066330A JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59066330A JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Publications (2)

Publication Number Publication Date
JPS60209530A true JPS60209530A (ja) 1985-10-22
JPH0144199B2 JPH0144199B2 (enExample) 1989-09-26

Family

ID=13312723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59066330A Granted JPS60209530A (ja) 1984-04-02 1984-04-02 殺腫瘍性物質

Country Status (1)

Country Link
JP (1) JPS60209530A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6377900A (ja) * 1986-09-18 1988-04-08 Sanwa Kagaku Kenkyusho Co Ltd ヤママユガ由来のレクチン様物質及びその分離精製法並びにその用途
US4960756A (en) * 1986-09-13 1990-10-02 Sanwa Kagaku Kenkyusho Co., Ltd. Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same
JP2016053003A (ja) * 2014-09-03 2016-04-14 学校法人 東洋大学 カイガラムシ由来のポリペプチド

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960756A (en) * 1986-09-13 1990-10-02 Sanwa Kagaku Kenkyusho Co., Ltd. Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same
JPS6377900A (ja) * 1986-09-18 1988-04-08 Sanwa Kagaku Kenkyusho Co Ltd ヤママユガ由来のレクチン様物質及びその分離精製法並びにその用途
JP2016053003A (ja) * 2014-09-03 2016-04-14 学校法人 東洋大学 カイガラムシ由来のポリペプチド

Also Published As

Publication number Publication date
JPH0144199B2 (enExample) 1989-09-26

Similar Documents

Publication Publication Date Title
US4390623A (en) Serum-free and mitogen-free T-cell growth factor and process for making same
JPS58157723A (ja) インタ−ロイキン２を含有してなる免疫療法剤
FR2522267A1 (fr) Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique
EP0090892A1 (en) Process for the purification of physiologically active substance having antitumour activity
JPS6154040B2 (enExample)
JPS6019719A (ja) 抗腫瘍活性を有する蛋白質
JPS60209530A (ja) 殺腫瘍性物質
EP0426924A1 (en) Production of metal transporter compositions for facilitating the engraftment of histo-incompatible bone marrow and controlling the immune reactions in the recipient host
US3852423A (en) Interferon inducer and process for preparing the same
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JPH09500262A (ja) 毒素結合性バイオポリマーの製造、その使用
JPS6019720A (ja) ヒト内来性癌制御因子およびその製造法
JPS63164895A (ja) 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
WO1984002912A1 (fr) Proteine a effet oncostatique, son procede de preparation et mediament oncostatique la contenant
JPS60208924A (ja) ヒト腫瘍壊死因子に対する抗体
JPS6245208B2 (enExample)
EP0161384A2 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same
SU1412596A3 (ru) Способ получени цитотоксических к раковым клеткам лимфоцитов и способ получени гликосв занного антигена
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
DE3236298C2 (enExample)
Niitani et al. Labilizing effect of lipoprotein lipase on lysosomes of tumor cells
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
Fritsch et al. Biochemical and Biological Characterization of Tumor-Associated Lymphokine-Like Factors
JPS5982315A (ja) 腫瘍壊死因子の製造法
JPH0446928B2 (enExample)